Results 101 to 110 of about 1,282 (161)

The Post-transplant Lymphoproliferative Disorders-Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and Protocol. [PDF]

Transplant Direct
Dharnidharka VR, Wylie KM, Wylie TN, Ruzinova MB, Goss CW, Storch GA, Mehta-Shah N, Byers D, Walther L, Jaza L, Gu H, Agarwal M, Green M, Moore E, Swerdlow SH, Silveira F, Marks LJ, Gratzinger D, Bagg A, Law SC, Gandhi M.   +20 more
europepmc   +1 more source

Posttransplant Lymphoproliferative Disorder (PTLD): 24 Years of Experience at a Referral Center in São Paulo, Brazil. Can Differences in Prevalence and Subtype of EBV Infection in the Population Influence the Results? A Retrospective Cohort Study. [PDF]

J Transplant
Vargas JC, Helman R, Durão MS, de Arruda EF, Afonso JE, Carraro RM, Curvelo LA, Felga GEG, Matielo CEL, Almeida PH, Pasqualin D, Stanzione R, Perrone C, Perini G, Hamerschlak N.   +14 more
europepmc   +1 more source

Core features and inherent diversity of post-acute infection syndromes. [PDF]

Front Immunol
Trautmann A.
europepmc   +1 more source

Cutaneous Epstein-Barr virus-positive polymorphous posttransplantation lymphoproliferative disorder responding to rituximab. [PDF]

JAAD Case Rep
Chen M, Hwang J, Germanas J.
europepmc   +1 more source

Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome. [PDF]

Pharmaceutics
Benkő BM, Szabó BI, Kádár S, Szabó E, Tóth G, Szente L, Tonka-Nagy P, Zelkó R, Sebe I.   +8 more
europepmc   +1 more source

Comorbidities and neurosurgical interventions in a cohort with connective tissue disorders. [PDF]

Front Neurol
Ruhoy IS, Bolognese PA, Rosenblum JS, Dass RA, Nayyer NS, Wood JD, Biggins JB.   +6 more
europepmc   +1 more source

Treatment of post-treatment Lyme disease symptoms-a systematic review. [PDF]

Eur J Neurol
Dersch R, Torbahn G, Rauer S.
europepmc   +1 more source

Isolated Muscular NK/T Cell Lymphoma: A Rare Presentation of Post-Transplant Lymphoproliferative Disorders. [PDF]

Indian J Nucl Med
Srivastava S, Jilhare P, Nazar AH, Ora M, Gambhir S.   +4 more
europepmc   +1 more source

EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity. [PDF]

Blood Cancer J
Atallah-Yunes SA, Habermann TM, Rees MJ, Ng LS, Durani U, Wang Y, King RL, Khurana A.   +7 more
europepmc   +1 more source